Cargando…

Induced myelopathy after long-term anti-tumor necrosis factor alpha treatment

Detalles Bibliográficos
Autores principales:	Modesto, C, Caracsegui, F, Melendo, S, Sanchez-Montanez, A, Roig, Manel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194460/ http://dx.doi.org/10.1186/1546-0096-9-S1-P111

Ejemplares similares

Etanercept-Induced Myelopathy in a Pediatric Case of Blau Syndrome
por: Caracseghi, Fabiola, et al.
Publicado: (2011)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Serum tumor necrosis factor alpha increased during remission with Etanercept
por: Spirchez, Mihaela, et al.
Publicado: (2011)

Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
por: Bayraktar, S, et al.
Publicado: (2008)

Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
por: Baraliakos, X, et al.
Publicado: (2005)

Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
por: Cavazzana, I, et al.
Publicado: (2005)

Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
por: Baraliakos, X, et al.
Publicado: (2005)

Tumor necrosis factor alpha reverses the immunosuppressive properties of mesenchymal stem cells in collagen-induced arthritis
por: Djouad, F, et al.
Publicado: (2005)

Resistance of rheumatoid arthritis synovial fibroblasts to p38 MAP-kinase inhibition of pro-destructive functions mediated by tumor necrosis factor alpha/tumor necrosis factor receptor-1
por: Kunisch, E, et al.
Publicado: (2005)

Repair of local bone erosions by combined treatment with parathyroid hormone, osteoprotegerin and anti-tumor necrosis factor in tumor necrosis factor-transgenic mice
por: Redlich, K, et al.
Publicado: (2003)

Tumor necrosis factor alpha downregulates bone morphogenetic protein expression and matrix macromolecule synthesis in articular cartilage
por: Bobacz, K, et al.
Publicado: (2004)

Long-term exposure of rheumatoid arthritis synovial fibroblasts to tumor necrosis factor alpha inhibits FasL-mediated apoptosis through activation of NF-κB and upregulation of the small ubiquitin-like modifier SUMO-1
por: Pap, T, et al.
Publicado: (2004)

Laminin, but not lipopolysaccharide, IL-1 or tumor necrosis factor alpha, induces IL-16 gene activity in synovial fibroblasts
por: Aicher, W, et al.
Publicado: (2003)

Tumor necrosis factor alpha induced proliferation of adult neural stem cells is mediated via NF-κB
por: Widera, Darius, et al.
Publicado: (2007)

Immunohistochemical study of tumor necrosis factor-alpha(TNF- α) expression in lung, liver, and spleen during aspergillosis infection
por: Dheeb, Batol Imran
Publicado: (2014)

Methotrexate, through adenosine release, downregulates tumor necrosis factor alpha-induced synovial fibroblast IL-15 expression and proliferation
por: Miranda, E, et al.
Publicado: (2005)

T cell contact-mediated induction of tumor necrosis factor alpha in peripheral blood monocytes is inhibited by autologous serum in rheumatoid arthritis
por: Wagner, U, et al.
Publicado: (2003)

Tumor necrosis factor alpha modulates fibroblast-like synoviocyte expression of lymphangiogenesis-associated vascular endothelial growth factor C
por: Connor, AM, et al.
Publicado: (2004)

Moderate hypothermia during cardiopulmonary bypass reduces intramyocardial expression of tumor necrosis factor alpha via inhibition of AP-1
por: Ma, Q, et al.
Publicado: (2005)

Opioid receptor expression on neutrophils: effect of tumour necrosis factor alpha treatment
por: Schmidt, A, et al.
Publicado: (2007)

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept
por: Baraliakos, X, et al.
Publicado: (2005)

Anti-tumor necrosis factor therapy in children with refractory Takayasu arteritis: report of five cases
por: Kostina, YO, et al.
Publicado: (2011)

Influence of variants of Fcg receptor IIA on the European league against rheumatism responses to anti-tumour necrosis factor alpha therapy in psoriatic arthritis
por: Ramirez, J, et al.
Publicado: (2010)

Risk factors for latent tuberculosis infection in RA patients treated with anti-tumor necrosis factor
por: Huang, Shiang-Fen, et al.
Publicado: (2012)

Inhibition of tumour necrosis factor alpha production by activated T cells of rheumatoid arthritis patients by novel anti-folate drugs: an ex vivo pilot study
por: van der Heijden, JW, et al.
Publicado: (2005)

The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis
por: Mullan, RH, et al.
Publicado: (2005)

Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
por: Baraliakos, X, et al.
Publicado: (2005)

Treatment of patients with HTLV-1-associated myelopathy with methotrexate
por: Ahmed, S, et al.
Publicado: (2014)

Abatacept (CTLA4-Ig) modulates human T-cell proliferation and cytokine production but does not affect lipopolysaccharide-induced tumor necrosis factor alpha production by monocytes
por: Davis, PM, et al.
Publicado: (2005)

Involvement of Th2 (interleukin-4) and Tumor necrosis factor-alpha in bowel disease pathogenesis through CD23/ no pathway: immunomodulatory effect of retinoic acid
por: Rafa, hayet, et al.
Publicado: (2014)

Impact of periprocedural myocardial necrosis on short term clinical outcome
por: Hamdi, M, et al.
Publicado: (2015)

Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load
por: Balandraud, N, et al.
Publicado: (2005)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

PReS-FINAL-2032: Changes in immunogenic profile in patients with juvenile idiopathic arthritis exposed to anti tumoral necrosis factor therapy
por: Guillen Astete, CA, et al.
Publicado: (2013)

Post-transcriptional regulation of tumor necrosis factor alpha expression
por: Brooks, S, et al.
Publicado: (2004)

Therapeutic inhibition of tumour necrosis factor alpha reduces oligoclonality in the selected T-cell receptor BV families in rheumatoid arthritis
por: Pierer, M, et al.
Publicado: (2003)

Vascular connexins have differing responses to tumor necrosis factor
por: Ouellette, Y
Publicado: (2009)

Circulating levels of tumor necrosis factor alpha, brain natriuretic peptide and cardiac Troponin I upon admission and 31-day mortality in patients with acute decompensated chronic heart failure
por: Zairis, P Batika, et al.
Publicado: (2007)

Interaction between etomidate and beta tumoral necrosis factor on hemodynamic response after cardiac surgery
por: Iribarren, JL, et al.
Publicado: (2015)

Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis
por: Schmeling, H, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vm3fe3s12bi0cg4ouj5an5h5e9